An Observational Study of Diagnostic Criteria, Clinical Features and Management of Opioid Induced Constipation (OIC) in European Patients With Cancer Pain

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

Constipation is common (40-90%) in advanced cancer patients , and has a significant negative impact on quality of life. The aetiology of constipation is often multifactorial in advanced cancer patients. However, it is well recognised that opioid analgesics are a common cause of constipation in this group. The prevalence of opioid-induced constipation (OIC) is stated to be 40-70%, although a recent large study reported an even higher figure. OIC has been reported to exceed pain in terms of distress caused, and studies have found that some patients choose to reduce or discontinue opioid medication in order to attempt to better control constipation. Moreover, OIC is associated with a variety of physical (gastrointestinal, systemic), psychological and social problems.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Age 18 years or over

• Diagnosis of cancer

• Diagnosis of cancer pain or cancer treatment-related pain

• Taking regular opioids for at least one week (i.e. opioid for mild to moderate pain / weak opioid; or opioid for moderate to severe pain / strong opioid)

Locations
Other Locations
Ireland
Norah Fagan
RECRUITING
Dublin
Contact Information
Primary
Norah Fagan
nfagan@olh.ie
01-4066235
Backup
Research Team
Researchteam@olh.ie
01-4066235
Time Frame
Start Date: 2021-09-16
Estimated Completion Date: 2024-07-31
Participants
Target number of participants: 1320
Related Therapeutic Areas
Sponsors
Leads: University of Dublin, Trinity College

This content was sourced from clinicaltrials.gov